The HemOnc Pulse Live at ASH: Srdan Verstovsek, MD, on MPN Treatment Combinations, Timing

Srdan Verstovsek, MD, of the University of Texas MD Anderson Cancer Center stopped by The HemOnc Pulse during the 64th American Society of Hematology Annual Meeting to discuss updates in research and treatment for myeloproliferative neoplasms (MPNs) with host Chadi Nabhan, MD, MBA, FACP. Dr. Verstovsek and Dr. Nabhan discussed topics including ruxolitinib-based combinations, a potential new standard of care for MPNs, considerations for timing myelofibrosis treatment, and more.